Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window

Inside Pharmaceuticals & Biotech

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech


aol.com > articles > aptar-pharma-massachusetts-general-hospital-210000000.html

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery - AOL

1+ hour, 1+ min ago   (184+ words) AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General Hospital (MGH)…...


eagletribune.com > region > aptar-pharma-and-massachusetts-general-hospital-collaborate-on-platform-to-establish-predictive-data-driven-model > article_15b6138a-3db2-5bb5-931c-d664e63deb7b.html

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

1+ hour, 1+ min ago   (231+ words) Eagle-Tribune Aptar and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Sep 14, 2026-- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer…...


reviewofoptometry.com > article > satralizumab-shows-clinically-meaningful-improvements-in-ted

Satralizumab Shows Clinically Meaningful Improvements in TED

8+ min ago   (202+ words) Adults aged 18 and older with either active, moderate to severe TED or inactive TED were included. Participants were randomized 1:1 to receive subcutaneous satralizumab or placebo. Dosing included a loading period at weeks zero, two and four, followed by every-four-week dosing....


minichart.com.sg > 09/14/2026 > biofrontera-wins-fda-approval-for-ameluz-in-superficial-basal-cell-carcinoma

Biofrontera Wins FDA Approval for Ameluz in Superficial Basal Cell Carcinoma

6+ hour, 25+ min ago   (296+ words) Minichart We value your privacy No cookies to display. Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features. Advertisement cookies are used to provide visitors with…...


servier.com > en > newsroom > cure51-research-partnership-glioblastoma

Servier and Cure51 launch a research partnership

7+ hour, 22+ min ago   (187+ words) While the prognosis remains extremely unfavorable for most patients, some outliers survive more than five years and are systematically identified through CURE51’s network of more than 150 oncology centers across 38 countries. Cure51 extracts and validates the biological mechanisms that underpin long-term survival,…...


tradingview.com > news > urn:summary_document_transcript:quartr.com:4167805:0-alxo-lead-assets-advance-toward-phase-iii-with-strong-biomarker-focus-and-robust-financial-runway

ALXO: Lead assets advance toward phase III, with strong biomarker focus and robust financial runway

2+ hour, 9+ min ago   (71+ words) TradingView ALXO: Lead assets advance toward phase III, with strong biomarker focus and robust financial runway Two lead programs are advancing toward pivotal studies, with evorpacept showing strong biomarker-driven efficacy and ALX2004 progressing through dose escalation in multiple tumor types. Financial…...


hcamag.com > us > specialization > employment-law > bart-loses-78-million-appeal-over-religious-vaccine-accommodation-denials > 589660

BART loses $7.8 million appeal over religious vaccine accommodation denials

5+ hour, 17+ min ago   (240+ words) Roles ranged from solo utility work to serving customers through bulletproof glass BART lost its appeal over a $7.8 million verdict after failing to prove that accommodating six religious objectors would have been an undue hardship. On September 11, 2026, the US Court…...


patch.com > new-jersey > lawrenceville > amp > 34/82/0770 > free-drive-through-vaccine-clinic-set-for-lawrence-township-tuesday

Free Drive-Through Vaccine Clinic Set For Lawrence Township Tuesday

1+ hour, 45+ min ago   (126+ words) Patch Free Drive-Through Vaccine Clinic Set For Lawrence Township Tuesday Lawrence Township Senior Center hosts flu and COVID-19 shots with CVS Pharmacy. LAWRENCEVILLE, NJ — The Lawrence Township Health Department, Lawrence Township Senior Center and CVS Pharmacy will host a drive-through…...


allsci.com > news > approvals > walvax-mrna-vaccine-china-approves-walvaxs-third

China approves Walvax’s third mRNA COVID-19 vaccine, targeting the Omicron JN.1 strain

7+ hour, 23+ min ago   (384+ words) AllSci China's National Medical Products Administration (NMPA) has approved a COVID-19 mRNA vaccine developed by Yuxi Watson Biotechnology Co., Ltd., a wholly-owned subsidiary of Yunnan-based Walvax Biotechnology Co., Ltd. (SZSE: 300142), for the prevention of COVID-19 in adults aged 18 years and…...